KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other Non-Current Assets (2018 - 2025)

ClearPoint Neuro's Other Non-Current Assets history spans 13 years, with the latest figure at $959000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 547.97% year-over-year to $959000.0; the TTM value through Sep 2025 reached $959000.0, up 547.97%, while the annual FY2024 figure was $735000.0, 574.31% up from the prior year.
  • Other Non-Current Assets for Q3 2025 was $959000.0 at ClearPoint Neuro, up from $720000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $959000.0 in Q3 2025 and bottomed at $56000.0 in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $131000.0 (2022), against an average of $228631.6.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 1114.02% in 2021 before it tumbled 37.75% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $125000.0 in 2021, then increased by 4.8% to $131000.0 in 2022, then fell by 16.79% to $109000.0 in 2023, then surged by 574.31% to $735000.0 in 2024, then soared by 30.48% to $959000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Other Non-Current Assets are $959000.0 (Q3 2025), $720000.0 (Q2 2025), and $148000.0 (Q1 2025).